As of 2024-07-27, the Relative Valuation of Oramed Pharmaceuticals Inc (ORMP) is 2.25 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.60 USD, the upside of Oramed Pharmaceuticals Inc based on Relative Valuation is -13.4%.
The range of the Relative Valuation is 1.60 - 3.79 USD.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 14.7x | 10.2x |
| Forward P/E multiples | 22.4x - 27.9x | 26.2x |
| Fair Price | 1.60 - 3.79 | 2.25 |
| Upside | -38.3% - 45.8% | -13.4% |
| Date | P/E |
| 2024-07-26 | 10.10 |
| 2024-07-25 | 9.86 |
| 2024-07-24 | 10.02 |
| 2024-07-23 | 10.21 |
| 2024-07-22 | 10.06 |
| 2024-07-19 | 9.90 |
| 2024-07-18 | 9.79 |
| 2024-07-17 | 9.98 |
| 2024-07-16 | 9.94 |
| 2024-07-15 | 9.83 |
| 2024-07-12 | 9.79 |
| 2024-07-11 | 9.67 |
| 2024-07-10 | 9.67 |
| 2024-07-09 | 9.71 |
| 2024-07-08 | 9.79 |
| 2024-07-05 | 9.94 |
| 2024-07-03 | 9.86 |
| 2024-07-02 | 10.00 |
| 2024-07-01 | 9.94 |
| 2024-06-28 | 9.98 |
| 2024-06-27 | 10.41 |
| 2024-06-26 | 9.98 |
| 2024-06-25 | 8.70 |
| 2024-06-24 | 8.66 |
| 2024-06-21 | 8.93 |
| 2024-06-20 | 8.58 |
| 2024-06-18 | 8.85 |
| 2024-06-17 | 8.70 |
| 2024-06-14 | 8.74 |
| 2024-06-13 | 8.87 |
| 2024-06-12 | 9.05 |
| 2024-06-11 | 8.04 |
| 2024-06-10 | 8.27 |
| 2024-06-07 | 8.16 |
| 2024-06-06 | 8.47 |
| 2024-06-05 | 8.58 |
| 2024-06-04 | 8.39 |
| 2024-06-03 | 8.58 |
| 2024-05-31 | 8.47 |
| 2024-05-30 | 8.70 |
| 2024-05-29 | 8.47 |
| 2024-05-28 | 8.54 |
| 2024-05-24 | 9.09 |
| 2024-05-23 | 9.01 |
| 2024-05-22 | 8.93 |
| 2024-05-21 | 8.97 |
| 2024-05-20 | 9.20 |
| 2024-05-17 | 8.93 |
| 2024-05-16 | 9.05 |
| 2024-05-15 | 9.28 |